WallStreetZenWallStreetZen

NASDAQ: MURA
Mural Oncology PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Mural Oncology earnings were -$147.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MURA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$48.0M, up 44.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MURA reported annual earnings of -$128.5M, with -38% growth. The next MURA earnings date is Nov 12, 2025.

MURA earnings history

Current Revenue
$0.0
Current Earnings
-$147.2M
Current Profit Margin
0%

MURA Return on Equity

Current Company
-122.3%
Current Industry
-10%
Current Market
30.7%
MURA's Return on Equity (-122.3%)... subscribe to Premium to read more.
High Return on Equity Performance

MURA undefined

Current Company
-99.4%
Current Industry
-0.2%
MURA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MURA announces earnings.

MURA undefined

Current Company
-248.83%
Current Industry
6.4%

MURA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MURA-$143.39M-$147.15MN/A-$8.59
DYAI-$5.09M-$5.58MN/A-$0.19
MRSN-$65.59M-$74.04MN/A-$14.62
SNTI-$49.48M-$54.79MN/A-$10.79
KLTO-$8.70M-$11.35MN/A-$0.45
View Top Biotech Stocks

MURA earnings dates

Next earnings date
Nov 12, 2025

Mural Oncology Earnings Reports & History FAQ

What were Mural Oncology's earnings last quarter?

On MURA's earnings call on Invalid Date, Mural Oncology (NASDAQ: MURA) reported Q2 2025 earnings per share (EPS) of -$2.78, up 49.46% year over year. Total MURA earnings for the quarter were -$47.98 million. In the same quarter last year, Mural Oncology's earnings per share (EPS) was -$1.86.

If you're new to stock investing, here's how to buy Mural Oncology stock.

When does Mural Oncology report earnings?

The next MURA earnings call is Invalid Date. Add MURA to your watchlist to be reminded of Mural Oncology's next earnings date.

Is Mural Oncology profitable or losing money?

As of the last Mural Oncology earnings report, Mural Oncology is currently losing money. Mural Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$147.15 million, a 15.09% decrease year over year.

What was MURA's earnings growth in the past year?

As of Mural Oncology's earnings date in Invalid Date, Mural Oncology's earnings has grown year over year. MURA earnings in the past year totalled -$147.15 million.

What are Mural Oncology's earnings expectations?

The current EPS estimate for Mural Oncology's earnings report in Invalid Date is -$0.30.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.